Home › Chronic-Phase Myeloid Leukemia › Alabama
Pag-aaral pangklinika para sa Chronic-Phase Myeloid Leukemia sa Alabama
3 pag-aaral para sa Chronic-Phase Myeloid Leukemia ang naghahanap ng mga kalahok sa mga site sa Alabama.
Mga Lungsod sa Alabama
Opisyal na teksto ng pag-aaral (English)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1044, Birmingham
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06423911A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- University of Alabama at Birmingham, Birmingham
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT07091019A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- University of Alabama Medicine (UAB Medicine), Birmingham
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT06163430Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.